DadFinStart your free week
DadFin › Stocks › Financial Services › OSG

Octave Specialty Group, Inc. (OSG) stock score

Financial Services · Insurance - Specialty · United States

$4.62 ▼ -3.14% today

3.1
Dad Score, out of 100
poor

Octave Specialty Group, Inc. (OSG) is a Insurance - Specialty company in the Financial Services sector, listed in the United States. On DadFin's weekly run it scores 3.1 out of 100 on the Dad Score, a poor reading that places the business ahead of 3% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Financial Services it ranks #1,218 of 1,228. Its strongest axis is macro; its weakest are valuation and quality.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Weak
Quality
Weak
Growth
Below average
Price action
Below average
Risk
Weak
Conviction
Below average
Liquidity
Average
Macro
Above average

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)0.0×
P/E (forward)8.3×
Dividend yield0.00%
Return on capital-11.2%
Operating margin-8.6%
Revenue growth (YoY)+5.7%
FCF yield-8.3%
Net debt / EBITDA6.26×
Piotroski F-Score2 / 9
52-week change-50.5%
Market cap$207M
Next earningsNov 9, 2026

What subscribers see on OSG

Start your free weekSubscriber? Open the full research →

Insurance - Specialty peers

StockCompanyDad ScoreBandMarket cap
FNFFidelity National Financial, Inc.67.3middling$10.5B
AXSAXIS Capital Holdings Limited94.2strong$7.0B
FAFFirst American Financial Corporati96.6strong$6.4B
ACTEnact Holdings, Inc.67.0middling$6.2B
MTGMGIC Investment Corporation61.6middling$5.5B
ESNTEssent Group Ltd.69.3middling$5.4B
RDNRadian Group Inc.63.0middling$4.3B
AGOAssured Guaranty Ltd.90.3strong$3.0B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.